Myasthenia gravis in pregnancy: Successful outcome with multidisciplinary management

Abstract

Myasthenia gravis (MG) is a rare autoimmune disorder characterized by nicotinic acetylcholine receptor autoantibodies, affecting the neuromuscular transmission leading to progressive weakness. MG during pregnancy is a high-risk condition that may affect both the mother and the fetus leading to adverse perinatal outcomes. We are presenting clinical course of two pregnant women, one of them was already diagnosed case of MG and second was diagnosed during postpartum period while waiting for discharge of baby. Literature review of the previously published cases and their management is also presented.